Using the co-design approach for developing and evaluating self-management intervention program for COPD patients in Nepal
Presenter: Uday Narayan Yadav
Supervisory team: Prof Mark Harris, A/Prof Jane Lloyd, Dr Hassan Hossainzadeh, and Prof Kedar P Baral
Date of PhD commencement: April 2018
Globally, Primary Health Care (PHC) is recognised as central to improving health for all, yet COPD patients in Nepal are not receiving adequate PHC, due to inadequate human resources for proper diagnosis and treatment and a lack of infrastructure. Therefore, there is a need to strengthen the capacity of community-level health institutions and health professionals in facilitating holistic care through linkages with tertiary level health facilities. Our study will be co-designing a model of care, which aims to find local solutions/innovations to the identified problems at the level of the patient, health professional and health system for improving self-management practices. We expect our program to greatly improve the quality of care and COPD patients’ quality of life in Nepal.
Valproate use during pregnancy in Australia- a population-based study
Presenter: Smriti Raichand
Supervisory team: Dr Alys Havard, Prof Sallie-Anne Pearson, Prof Nicholas Buckley, Dr Helga Zoega
Date of PhD commencement: March 2016
Valproate is subsidised in Australia for treatment of epilepsy and bipolar disorders. When used in pregnancy valproate is known to cause fetal malformations such as neural tube defects. Recent therapeutic guidelines strictly contraindicate use of valproate in pregnant women and women of child-bearing age, with the exception of epilepsy, following new evidence on long-term neurodevelopmental disorders in children exposed in utero. There is little or no knowledge about the extent and reasons for its use in Australia. There is an urgent need to investigate the reasons for which valproate is prescribed to pregnant women in Australia to avoid unnecessary exposure. In this study we aimed to describe the utilisation of valproate in pregnant women and examine the reasons for its use in women who gave birth in New South Wales between 2004 and 2012, using linked population-based datasets comprising the birth records, hospitalisation records and medicine prescription records.